ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,262.08
1.38%
Dow Jones
44,296.51
0.97%
Gold vs US Dollar
2,715.28
0.00%
Brent Oil
74.65
0.00%
Bitcoin
97,108.38
-0.69%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSXV
  6. Cannara Biotech Inc (LOVE)

  7. Cannara Biotech Inc (LOVE) News

Cannara Biotech (LOVE)

Cannara Biotech Inc
Date:
Sort by:
 Showing the most relevant articles for your search:TSXV:LOVE
DateTimeSourceHeadlineSymbolCompany
29/04/202419:00PR Newswire (Canada)Cannara Biotech publie ses résultats financiers pour le deuxième trimestre de 2024TSXV:LOVECannara Biotech Inc
29/04/202419:00PR Newswire (Canada)Cannara Biotech Reports Q2 2024 Financial ResultsTSXV:LOVECannara Biotech Inc
30/01/202413:30PR Newswire (Canada)Cannara Biotech annonce des résultats records pour le premier trimestre de 2024 : Croissance robuste continue et expansion du marchéTSXV:LOVECannara Biotech Inc
30/01/202413:30PR Newswire (Canada)Cannara Biotech Announces Record-Breaking Q1 2024 Results: Continued Robust Growth and Market ExpansionTSXV:LOVECannara Biotech Inc
08/01/202413:30PR Newswire (Canada)Cannara Biotech annonce l'engagement d'Independent Trading Group (ITG) pour la prestation de services de teneur de marchéTSXV:LOVECannara Biotech Inc
08/01/202413:30PR Newswire (Canada)Cannara Biotech Announces Engagement of Market Maker Services from Independent Trading Group ("ITG")TSXV:LOVECannara Biotech Inc
13/12/202315:30PR Newswire (Canada)Cannara Biotech annonce la tenue virtuelle de son assemblée générale annuelle des actionnaires le 25 janvier 2024TSXV:LOVECannara Biotech Inc
13/12/202315:30PR Newswire (Canada)Cannara Biotech Announces Notice Of Annual General Meeting Of Shareholders To Be Held Virtually On January 25th, 2024TSXV:LOVECannara Biotech Inc
11/12/202313:30PR Newswire (Canada)Cannara Biotech tiendra une webdiffusion à l'intention des investisseurs le jeudi 14 décembre 2023TSXV:LOVECannara Biotech Inc
11/12/202313:30PR Newswire (Canada)Cannara Biotech to Host Investor Webcast on Thursday December 14th, 2023TSXV:LOVECannara Biotech Inc
07/12/202313:30PR Newswire (Canada)Cannara Biotech Inc. publie les résultats du quatrième trimestre et de l'exercice financier 2023 Poursuite de la croissance et de la rentabilité recordsTSXV:LOVECannara Biotech Inc
07/12/202313:30PR Newswire (Canada)Cannara Biotech Reports Fourth Quarter and 2023 Fiscal Year Results: Record Growth and Profitability ContinuesTSXV:LOVECannara Biotech Inc
27/07/202312:00PR Newswire (Canada)Cannara Biotech Inc. Reports Record Q3 2023 Financial Results with Net Revenues of $15.9 Million and Net Income of $2.9 millionTSXV:LOVECannara Biotech Inc
27/07/202312:00PR Newswire (Canada)Cannara Biotech Inc. publie ses résultats financiers pour le T3 de 2023, avec des recettes nettes trimestrielles de 15,9 millions de dollars et un bénéfice net de 2,9 millions de dollarsTSXV:LOVECannara Biotech Inc
11/05/202312:00PR Newswire (Canada)Cannara Biotech Inc. To Participate At Canaccord Genuity's 7th Annual Global Cannabis ConferenceTSXV:LOVECannara Biotech Inc
11/05/202312:00PR Newswire (Canada)Cannara Biotech Inc. participera à la septième conférence annuelle mondiale sur le cannabis de Canaccord GenuityTSXV:LOVECannara Biotech Inc
04/05/202312:00PR Newswire (Canada)CANARA BIOTECH INC. SECURES AN ADDITIONAL $10 MILLION IN NON-DILUTIVE CAPITAL WITH ITS LEAD CREDIT PROVIDER, BMO COMMERCIAL BANKINGTSXV:LOVECannara Biotech Inc
04/05/202312:00PR Newswire (Canada)CANNARA BIOTECH INC. OBTIENT 10 MILLIONS DE DOLLARS SUPPLÉMENTAIRES EN CAPITAL NON DILUTIF AUPRÈS DE SON PRINCIPAL FOURNISSEUR DE CRÉDIT, LES SERVICES BANCAIRES AUX GRANDES ENTREPRISES DE BMOTSXV:LOVECannara Biotech Inc
25/04/202312:00PR Newswire (Canada)Cannara Biotech Inc. to Host Investor Webcast on May 4th, 2023TSXV:LOVECannara Biotech Inc
25/04/202312:00PR Newswire (Canada)Cannara Biotech Inc. tiendra une webdiffusion à l'intention des investisseurs le 4 mai 2023TSXV:LOVECannara Biotech Inc
24/04/202312:00PR Newswire (Canada)Cannara Biotech Inc. présente ses résultats financiers du deuxième trimestre 2023 assortis de revenus nets trimestriels de 13 millions de dollars, une augmentation de 76% par rapport au deuxième trimestre de 2022TSXV:LOVECannara Biotech Inc
24/04/202312:00PR Newswire (Canada)Cannara Biotech Inc. reports Q2 2023 Financial Results with quarterly net revenues of $13 million, a 76% increase compared to Q2 2022TSXV:LOVECannara Biotech Inc
28/02/202320:45PR Newswire (Canada)Cannara met sur pied un régime d'achat automatique d'actionsTSXV:LOVECannara Biotech Inc
28/02/202320:45PR Newswire (Canada)Cannara Biotech Inc. Enters into an Automatic Share Purchase PlanTSXV:LOVECannara Biotech Inc
10/02/202313:00PR Newswire (Canada)CANNARA BIOTECH INC. ANNOUNCES RESULTS OF ANNUAL SHAREHOLDER MEETING AND CONVERSION INTO EQUITY OF A $5M CONVERTIBLE DEBENTURE AT $0.18 CENT PER COMMON SHARETSXV:LOVECannara Biotech Inc
10/02/202313:00PR Newswire (Canada)CANNARA BIOTECH INC. ANNONCE LES RÉSULTATS DE SON ASSEMBLÉE ANNUELLE DES ACTIONNAIRES ET LA CONVERSION EN CAPITAUX PROPRES DE DÉBENTURES CONVERTIBLES D'UNE VALEUR DE 5 MILLIONS DE DOLLARS AU PRIX DE 0,18 $ PAR ACTION ORDINAIRETSXV:LOVECannara Biotech Inc
23/01/202313:00PR Newswire (Canada)Cannara Biotech Inc. présente ses résultats financiers du premier trimestre 2023TSXV:LOVECannara Biotech Inc
23/01/202313:00PR Newswire (Canada)Cannara Biotech Inc. Reports Q1 2023 Financial ResultsTSXV:LOVECannara Biotech Inc
12/01/202314:00PR Newswire (Canada)Cannara annonce une proposition de regroupement d'actionsTSXV:LOVECannara Biotech Inc
12/01/202314:00PR Newswire (Canada)Cannara Announces Proposed Share ConsolidationTSXV:LOVECannara Biotech Inc
 Showing the most relevant articles for your search:TSXV:LOVE

Your Recent History

LSE
VAST
Vast Resources
LSE
SYME
Supply@me Capital
LSE
POS
Plexus
LSE
ITV
Itv
LSE
MTRO
Metro Bank
LSE
ZED
Zenova
LSE
TERN
Tern
LSE
LLOY
Lloyds Banking
LSE
ALBA
Alba Mineral Resources
LSE
GDR
Genedrive
LSE
SBTX
Skinbiotherapeutics
LSE
GOLD
LSE
AAZ
Anglo Asian Mining
LSE
GKP
Gulf Keystone Petroleum
LSE
NEXN
Nexxen
LSE
SRSP
Sirius Petroleum
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Level 2 Lite

    1 year 40%, 2 years 50% and *3 years 60%

    *Across 3 years £2132.64 only £853.06